Pendulum (GLP-1 Probiotic) Review 2026
Reviewed August 7, 2026 · Dietary supplement — a live-strain probiotic. Not a medication, not a GLP-1 agonist, and not FDA-approved for any indication.
Visit Pendulum (GLP-1 Probiotic) WebsiteOverview
Pendulum's GLP-1 Probiotic is a dietary supplement, not a medication, and the single most important thing to understand about it is contained in Pendulum's own sentence: it 'does not contain GLP-1 and is not a GLP-1 agonist drug'. If you found this product while researching tirzepatide, it is not an alternative to it and does not do what it does. Credit where due — Pendulum says so explicitly, and also labels its claims 'Based on preclinical studies. Not intended for weight loss'. Those are honest disclosures that many supplement companies would omit. The formulation is also more serious than most: three named strains — Akkermansia muciniphila, Clostridium butyricum and Bifidobacterium infantis — delivered in a plant-based, acid-resistant delayed-release capsule, which is a real formulation concern for oxygen-sensitive anaerobes rather than marketing dressing. Akkermansia muciniphila is a legitimate object of metabolic research, associated in studies with gut barrier function and metabolic markers. What the evidence does not currently support is the leap from that research to meaningful weight or appetite outcomes in humans. Pendulum's headline figures — '91% reported reduced overall food cravings' and '88% reported fewer sugar cravings' — come, by its own disclosure, from 'a consumer survey of 274 people taking GLP-1 Probiotic for six weeks'. A consumer survey of self-reported cravings is close to the weakest evidence design available for an appetite claim: unblinded, uncontrolled, self-selected and self-reported.
Medications Offered
Brand-name or compounded: Dietary supplement — a live-strain probiotic. Not a medication, not a GLP-1 agonist, and not FDA-approved for any indication.
- Akkermansia muciniphila — described as generating postbiotics that support GLP-1 signalling
- Clostridium butyricum — described as producing postbiotics supporting gut health and GLP-1
- Bifidobacterium infantis — described as generating postbiotics supporting GLP-1 signalling
- Delivered in a plant-based, acid-resistant, delayed-release capsule
- Contains no GLP-1 and is not a GLP-1 receptor agonist
Consultation Process
No consultation required
This is a dietary supplement sold direct to consumers. No prescription, medical intake or clinician review is involved.
Order the product
Available on a one-off or subscription basis. No price appeared on the page we reviewed; a 30% referral discount and $30 first-order minimum were referenced.
Daily capsule
Taken daily as an acid-resistant delayed-release capsule designed to deliver live anaerobic strains past stomach acid.
Eligibility
- Sold as a general dietary supplement to adults
- Not a treatment for obesity or any medical condition
- Discuss with a clinician if you are immunocompromised — live-strain probiotics warrant caution in that group
- Discuss with a clinician before combining with prescribed GLP-1 therapy
- No prescription or medical assessment required
Provider Involvement
None. This is a consumer supplement with no clinical service attached — no prescriber, no monitoring, no follow-up. That is not a criticism of a supplement as such, but it means nobody is assessing whether this is appropriate for you or whether something else would serve you better.
Lab Requirements
None. No testing is involved or offered.
Pharmacy Fulfillment
Not applicable — this is a supplement, not a compounded or prescription product.
Shipping Frequency
Available on subscription; specific cadence and shipping terms were not published on the page we reviewed.
Membership Fees vs. Medication Fees
Membership fees
None. Subscription pricing may apply; terms were not published on the page we reviewed.
Medication fees
- No product price published on the page we reviewed
- A '30% referral discount applied at checkout' and a '$30 minimum' first order were referenced
Cancellation & Refund Policy
Cancellation
Not published on the page we reviewed. Confirm subscription cancellation terms before ordering.
Refunds
Not published on the page we reviewed.
Insurance
Not applicable. Dietary supplements are not covered by insurance.
HSA / FSA
Not stated. Dietary supplements are generally not HSA/FSA eligible without a letter of medical necessity.
See our GLP-1 insurance and HSA/FSA guide for how reimbursement works in practice.
Support Services
- Direct-to-consumer supplement purchase
- Subscription option
- Published strain list and delivery mechanism
State Availability
Not applicable — sold as a consumer supplement.
Pros
- States plainly that the product 'does not contain GLP-1 and is not a GLP-1 agonist drug'
- Labels its own claims as 'Based on preclinical studies. Not intended for weight loss'
- Names its specific strains rather than hiding behind a proprietary blend
- Akkermansia muciniphila is a genuinely researched organism in metabolic health
- Uses an acid-resistant delayed-release capsule, which matters for anaerobe survival
- Discloses that its headline percentages come from a consumer survey, with the sample size stated
Cons
- The product name invites exactly the confusion its own disclaimers then have to correct
- '91% reported reduced food cravings' comes from a 274-person consumer survey, not a clinical trial
- Self-reported craving data is among the weakest evidence types for an appetite claim
- This is a supplement, not a treatment — it will not do what tirzepatide does
- No pricing was published on the page we reviewed
- Akkermansia's metabolic research is mostly preclinical or small-scale in humans
Who Pendulum (GLP-1 Probiotic) May Be Best For
- People interested in gut microbiome supplementation for its own sake, with realistic expectations
- Readers who want to understand why a 'GLP-1 probiotic' is not a GLP-1 medication
Limitations
- Not a treatment and not comparable to GLP-1 medication
- Headline claims rest on a 274-person consumer survey
- Human evidence for metabolic outcomes remains limited
- No pricing published
Reputation & Trust
Pendulum is more honest than the average supplement company and still oversells, and both halves of that deserve stating. The honesty is real: it says outright that the product 'does not contain GLP-1 and is not a GLP-1 agonist drug', labels its claims 'Based on preclinical studies. Not intended for weight loss', names its three specific strains rather than hiding behind a proprietary blend, explains its delayed-release delivery mechanism, and discloses that its headline percentages come from a consumer survey with the sample size given. Very few supplement brands volunteer that much. The overselling is in the framing rather than the fine print. Naming a probiotic 'GLP-1 Probiotic' creates precisely the impression the disclaimers then have to walk back, and the '91% reported reduced overall food cravings' figure — from 274 unblinded, self-selected people reporting on their own cravings over six weeks — carries almost no weight as evidence. Akkermansia muciniphila is a genuinely interesting organism in metabolic research, but that research is largely preclinical or small-scale in humans, and it does not currently support meaningful weight outcomes. For readers of this site the practical conclusion is simple: this is not a substitute for a GLP-1 medication, and Pendulum agrees.
What Makes Pendulum (GLP-1 Probiotic) Different
- Explicitly states it is not a GLP-1 agonist and not intended for weight loss
- Names all three strains and the delivery mechanism
- Akkermansia muciniphila is a real subject of metabolic research
- Discloses the survey basis and sample size for its own claims
Our Verdict
Pendulum's GLP-1 Probiotic earns 3/5, and the rating reflects a genuine split. On disclosure it does considerably better than the supplement category norm: it states outright that the product 'does not contain GLP-1 and is not a GLP-1 agonist drug', labels its claims 'Based on preclinical studies. Not intended for weight loss', names all three strains instead of hiding behind a proprietary blend, explains its acid-resistant delayed-release delivery, and tells you its headline percentages came from a consumer survey of 274 people. That is more candour than most supplement brands offer, and Akkermansia muciniphila is a real object of metabolic research rather than an invented ingredient. But the product is named in a way that creates exactly the misconception its own disclaimers then have to correct, and '91% reported reduced food cravings' from an unblinded, uncontrolled, self-reported six-week survey is not evidence of anything much. For anyone who arrived here from a tirzepatide search, the practical answer is the one Pendulum itself provides: this is not that, and it will not do what that does. As a microbiome supplement bought with realistic expectations, it is among the better-documented options. As a GLP-1 alternative, it is not one.
Alternatives to Pendulum (GLP-1 Probiotic)
If you want actual GLP-1 treatment, the clearest efficacy disclosure in this directory.
FDA-approved weight-loss medication through board-certified physicians, including non-GLP-1 options.
The only provider here publishing peer-reviewed patient outcomes.
If you want data on your own metabolic markers rather than a supplement.
Compare more options on our best online GLP-1 providers and cheapest GLP-1 programs pages.
Frequently Asked Questions
Is Pendulum's GLP-1 Probiotic an alternative to tirzepatide or semaglutide?
No, and Pendulum states this itself: the product 'does not contain GLP-1 and is not a GLP-1 agonist drug'. It is a dietary supplement containing live bacterial strains. GLP-1 receptor agonists such as tirzepatide and semaglutide are prescription medications that act directly on GLP-1 receptors and have been studied in large randomised trials. These are not comparable products, and the supplement will not produce the effects the medication does.
What does the '91% reported reduced food cravings' figure actually mean?
Less than it sounds, and Pendulum discloses why. That figure comes from 'a consumer survey of 274 people taking GLP-1 Probiotic for six weeks'. A consumer survey is unblinded, uncontrolled and self-reported, with participants who chose to buy the product and knew what they were taking — which is the design most vulnerable to placebo effect and reporting bias. It is not a clinical trial result and should not be read as one.
Is Akkermansia muciniphila worth taking?
It is a legitimate subject of metabolic research — associated in studies with gut barrier integrity and metabolic markers — but the evidence in humans remains limited and largely preclinical or small-scale. Pendulum's own labelling says its claims are 'Based on preclinical studies. Not intended for weight loss.' If you find microbiome supplementation interesting on its own terms, that is a reasonable reason to try it. Expecting weight loss is not.
Can I take this alongside a prescribed GLP-1?
Discuss it with the clinician managing your treatment first. There is no obvious mechanism for harm in most people, but live-strain probiotics warrant caution in anyone immunocompromised, and your prescriber should know everything you are taking. Do not substitute it for prescribed medication.
Important Notes & Warnings
- This review is informational only and is not medical advice. Consult a licensed clinician before starting any supplement, particularly alongside prescribed medication.
- This product is a dietary supplement, NOT a medication. Pendulum states it 'does not contain GLP-1 and is not a GLP-1 agonist drug'. It is not a substitute for prescribed GLP-1 therapy.
- Pendulum labels its own claims 'Based on preclinical studies. Not intended for weight loss.'
- The '91% reported reduced overall food cravings' and '88% reported fewer sugar cravings' figures come from an unblinded, uncontrolled consumer survey of 274 people — not a clinical trial.
- Dietary supplements are not FDA-approved and are not evaluated for efficacy before marketing.
- Live-strain probiotics warrant caution in immunocompromised people — speak to a clinician first.
- Do not stop or delay prescribed treatment in favour of a supplement.
Sources
- Pendulum GLP-1 Probiotic product page, pendulumlife.com (accessed 7 August 2026)
- Pendulum's own disclosure that its craving figures derive from a consumer survey of 274 people over six weeks
Medical Disclaimer
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Talk to a healthcare provider before starting, changing, or stopping any treatment, and call emergency services for urgent symptoms.
Facts in this review were compiled from the provider's own public website and public search results as of August 7, 2026. Prices, medication availability, pharmacy partners, and policies change frequently and vary by state — verify everything directly with the provider before purchasing.
This page contains affiliate links. We may earn a commission from qualifying purchases at no additional cost to you.